Joint Formulary & PAD

Epoprostenol sodium - Pulmonary arterial hypertension

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
Associated Icons :
R
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Epoprostenol sodium
Indication :
Pulmonary arterial hypertension
Group Name :
Keywords :
PAH
Brand Names Include :
Flolan
Important Information :

ITU use only - in patients too unstable for transfer to tertiary care.
Not for routine use - commissioned by NHSE from specialist centres only.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Epoprostenol sodium is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Pulmonary arterial hypertension.

Committee Recommendations (0)

  • No records returned.